Home/Filings/4/0001209191-22-037850
4//SEC Filing

Turner William D. 4

Accession 0001209191-22-037850

CIK 0001290149other

Filed

Jun 16, 8:00 PM ET

Accepted

Jun 17, 4:17 PM ET

Size

5.7 KB

Accession

0001209191-22-037850

Insider Transaction Report

Form 4
Period: 2022-06-17
Turner William D.
Chief Reg & Tech Ops Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-06-17+12,25012,250 total
    Exercise: $12.15From: 2022-06-17Exp: 2030-08-12Common Stock (12,250 underlying)
Footnotes (1)
  • [F1]On August 12, 2020, the reporting person was granted an option to purchase 49,000 shares of common stock. The option vests based on the satisfaction by Issuer of certain performance criteria. The achievement of one of the performance criteria resulted in vesting of the option as to 12,250 shares.

Issuer

Sierra Oncology, Inc.

CIK 0001290149

Entity typeother

Related Parties

1
  • filerCIK 0001819688

Filing Metadata

Form type
4
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 4:17 PM ET
Size
5.7 KB